Search

Author/Creator Gerstner, Gregory

1. 360 A phase 1 study of an Off-the-Shelf, multi-neoantigen vector (ADXS-503) alone and in combination with pembrolizumab in subjects with metastatic non-small cell lung cancer (NSCLC). (10th December 2020)

Authors:
Goldman, Jonathan; Stinchcombe, Thomas; Gerstner, Gregory; Haigentz, Missak; Vangala, Surya; Parsi, Megan; Kabala, Victor; Simkhada, Dinesh; Gutierrez, Andres; Ramalingam, Suresh
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A220
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 360 A phase 1 study of an Off-the-Shelf, multi-neoantigen vector (ADXS-503) alone and in combination with pembrolizumab in subjects with metastatic non-small cell lung cancer (NSCLC). (9th November 2020)

Authors:
Goldman, Jonathan; Stinchcombe, Thomas; Gerstner, Gregory; Haigentz, Missak; Vangala, Surya; Parsi, Megan; Kabala, Victor; Simkhada, Dinesh; Gutierrez, Andres; Ramalingam, Suresh
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A385
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search